Alzheimer's disease and its treatment costs: case study in the Czech Republic

Código QR

Alzheimer's disease and its treatment costs: case study in the Czech Republic

Hana Mohelska,1 Petra Maresova,2 Martin Valis,3 Kamil Kuca4,5 1Department of Management, 2Department of Economy, Faculty of Informatics and Management, University of Hradec Králové, 3Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Kr&aa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohelska H, Maresova P, Valis M, Kuca K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/d56d38f9115b403aa3ad9a9950902d58
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
por: Wallin &Aring;K, et al.
Publicado: (2011)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
por: Klimova B, et al.
Publicado: (2018)

Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors
por: Černý M, et al.
Publicado: (2018)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
por: Tran T, et al.
Publicado: (2011)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
por: Nakaaki S, et al.
Publicado: (2012)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
por: Tomaskova H, et al.
Publicado: (2016)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
por: Chiou CF, et al.
Publicado: (2015)

Editor&#39;s choice
por: Pinder RM
Publicado: (2012)

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
por: Yoshimura B, et al.
Publicado: (2013)

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
por: Wu J, et al.
Publicado: (2015)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
por: Goetz M, et al.
Publicado: (2015)

Gene–Environment Interactions in Major Mental Disorders in the Czech Republic
por: Latalova K, et al.
Publicado: (2020)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi B
Publicado: (2015)

Assistive technologies for managing language disorders in dementia
por: Klimova B, et al.
Publicado: (2016)

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
por: Musil F, et al.
Publicado: (2018)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
por: Hinz M, et al.
Publicado: (2016)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
por: Gaines KD, et al.
Publicado: (2012)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
por: Liu WM, et al.
Publicado: (2015)

A case of early onset Parkinson's disease after major stress
por: Zou K, et al.
Publicado: (2013)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
por: Sabrina Schr&ouml;der, et al.
Publicado: (2011)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease
por: McKinlay A, et al.
Publicado: (2013)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang L, et al.
Publicado: (2014)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo E, et al.
Publicado: (2015)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
por: Kishi T, et al.
Publicado: (2017)

The cost of schizophrenia in Japan
por: Sado M, et al.
Publicado: (2013)

The societal costs of insomnia
por: Alan G Wade
Publicado: (2010)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)